Mandie S. White

Mandie S. White serves as a Contracting Officer responsible for managing complex scientific and technical acquisitions aligned with federal research and development priorities. In her role, she ensures compliance with federal acquisition regulations while facilitating the procurement of high-value R&D services critical to advancing public science initiatives. She typically handles competitive solicitations under FAR Part 15, including requirements for technical proposals, performance-based statements of work, and cost-reimbursement contract types. Her work supports mission-critical innovation by bridging agency objectives with the capabilities of specialized scientific contractors. While specific contractor names are not available, Mandie consistently engages with firms possessing deep expertise in biotechnology and life sciences research, fostering long-term vendor partnerships grounded in technical rigor and regulatory compliance. Her procurement approach emphasizes merit-based selection, with a focus on proposers demonstrating proven capabilities in experimental design, data analysis, and translational research. She maintains a collaborative relationship with technical evaluators and program managers to ensure contract deliverables align with scientific objectives and federal oversight standards. Mandie’s contracting patterns reflect a strong preference for full and open competition, with 100% of her awards issued without set-asides. This indicates a deliberate focus on selecting the most technically qualified offerors regardless of socioeconomic status, rather than prioritizing 8(a), HUBZone, or SDVOSB programs. While small business participation is not structurally mandated in her portfolio, she remains attentive to the capabilities of small firms that meet stringent technical criteria, ensuring fair and equitable access within the competitive landscape. Her primary procurement focus lies in NAICS 541714 (Biotechnology R&D) and 541715 (Physical, Engineering, and Life Sciences R&D), where she procures services such as preclinical testing, clinical trial design, analytical method development, and laboratory automation systems. Mandie possesses specialized expertise in evaluating scientific proposals, managing intellectual property clauses, and ensuring compliance with federal biosafety and data integrity standards, making her a key steward of high-stakes scientific innovation contracts.